YD Bio (NASDAQ:YDES) Sees Strong Trading Volume – Should You Buy?

YD Bio Limited (NASDAQ:YDES) shares saw unusually-strong trading volume on Friday. Approximately 433,562 shares changed hands during mid-day trading, an increase of 201% from the previous session’s volume of 144,131 shares. The stock last traded at $7.8650 and had previously closed at $7.81.

Analysts Set New Price Targets

Separately, Wall Street Zen upgraded YD Bio to a “hold” rating in a research report on Saturday, September 26th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the company presently has a consensus rating of “Sell”.

YD Bio Stock Performance

The company’s 50-day moving average is $3.74 and its 200-day moving average is $4.16.

YD Bio (NASDAQ:YDES) last posted its earnings results on Tuesday, September 1st. The biotechnology company reported $0.05 earnings per share for the quarter. The firm had revenue of $0.42 million during the quarter.

Institutional Investors Weigh In On YD Bio

A hedge fund recently raised its stake in YD Bio stock. Cypress Capital Management LLC WY raised its holdings in YD Bio Limited (NASDAQ:YDES) by 9.8% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 33,690 shares of the biotechnology company’s stock after purchasing an additional 3,000 shares during the quarter. Cypress Capital Management LLC WY’s holdings in YD Bio were worth $76,000 as of its most recent SEC filing.

About YD Bio

YD Bio Limited is a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations.